5-119116244-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_001290321.3(DMXL1):c.651C>T(p.Ser217=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00196 in 1,613,934 control chromosomes in the GnomAD database, including 65 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.011 ( 30 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 35 hom. )
Consequence
DMXL1
NM_001290321.3 synonymous
NM_001290321.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.346
Genes affected
DMXL1 (HGNC:2937): (Dmx like 1) The protein encoded by this gene is a member of the WD repeat superfamily of proteins, which have regulatory functions. This gene is expressed in many tissue types including several types of eye tissue, and it has been associated with ocular phenotypes. In addition, it is upregulated in cultured cells that overexpress growth factor independence 1B, a transcription factor that is essential for hematopoietic cell development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 5-119116244-C-T is Benign according to our data. Variant chr5-119116244-C-T is described in ClinVar as [Benign]. Clinvar id is 713080.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.346 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0107 (1626/152136) while in subpopulation AFR AF= 0.0375 (1554/41494). AF 95% confidence interval is 0.0359. There are 30 homozygotes in gnomad4. There are 762 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 30 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMXL1 | NM_001290321.3 | c.651C>T | p.Ser217= | synonymous_variant | 7/44 | ENST00000539542.6 | NP_001277250.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMXL1 | ENST00000539542.6 | c.651C>T | p.Ser217= | synonymous_variant | 7/44 | 1 | NM_001290321.3 | ENSP00000439479 | A1 | |
DMXL1 | ENST00000311085.8 | c.651C>T | p.Ser217= | synonymous_variant | 7/43 | 1 | ENSP00000309690 | P3 | ||
DMXL1 | ENST00000503802.5 | c.651C>T | p.Ser217= | synonymous_variant | 8/13 | 1 | ENSP00000427692 | |||
DMXL1 | ENST00000514151.1 | n.323C>T | non_coding_transcript_exon_variant | 4/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0107 AC: 1625AN: 152018Hom.: 30 Cov.: 32
GnomAD3 genomes
AF:
AC:
1625
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00262 AC: 659AN: 251412Hom.: 9 AF XY: 0.00188 AC XY: 255AN XY: 135878
GnomAD3 exomes
AF:
AC:
659
AN:
251412
Hom.:
AF XY:
AC XY:
255
AN XY:
135878
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00105 AC: 1534AN: 1461798Hom.: 35 Cov.: 32 AF XY: 0.000894 AC XY: 650AN XY: 727196
GnomAD4 exome
AF:
AC:
1534
AN:
1461798
Hom.:
Cov.:
32
AF XY:
AC XY:
650
AN XY:
727196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0107 AC: 1626AN: 152136Hom.: 30 Cov.: 32 AF XY: 0.0102 AC XY: 762AN XY: 74348
GnomAD4 genome
AF:
AC:
1626
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
762
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
DMXL1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 08, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at